Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status

2019 
Introduction Our aim was to assess efficacy and safety and prognostic factors associated with TAS-102 in clinical practice.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    12
    References
    1
    Citations
    NaN
    KQI
    []